The rapidly growing field of toxicoepigenetics seeks
to understand
how toxicant exposures interact with the epigenome to influence disease
risk. Toxicoepigenetics is a promising field of environmental health
research, as integrating epigenetics into the field of toxicology
will enable a more thorough evaluation of toxicant-induced disease
mechanisms as well as the elucidation of the role of the epigenome
as a biomarker of exposure and disease and possible mediator of exposure
effects. Likewise, toxicoepigenetics will enhance our knowledge of
how environmental exposures, lifestyle factors, and diet interact
to influence health. Ultimately, an understanding of how the environment
impacts the epigenome to cause disease may inform risk assessment,
permit noninvasive biomonitoring, and provide potential opportunities
for therapeutic intervention. However, the translation of research
from this exciting field into benefits for human and animal health
presents several challenges and opportunities. Here, we describe four
significant areas in which we see opportunity to transform the field
and improve human health by reducing the disease burden caused by
environmental exposures. These include (1) research into the mechanistic
role for epigenetic change in environment-induced disease, (2) understanding
key factors influencing vulnerability to the adverse effects of environmental
exposures, (3) identifying appropriate biomarkers of environmental
exposures and their associated diseases, and (4) determining whether
the adverse effects of environment on the epigenome and human health
are reversible through pharmacologic, dietary, or behavioral interventions.
We then highlight several initiatives currently underway to address
these challenges.